Globus Medical, Inc. (GMED) Stock

NYSE: GMEDDesigns and manufactures musculoskeletal implants and instruments for patients with spine disorders.

Globus Medical stock price chart

GMED stock quote & key statistics

Globus Medical earnings per share

Income →
Earnings per share

Globus Medical revenue & net income

Income →
RevenueNet income

Globus Medical annual financials

Income statement →
Globus Medical, Inc. revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2025$2.94B$537.9M$4.00
FY2024$2.52B$103.0M$3.14
FY2023$1.57B$122.9M$2.33
FY2022$1.02B$190.2M$2.07
FY2021$958.1M$149.2M$2.04

Fiscal year ending December 31. Source: company filings via EODHD.

About Globus Medical, Inc.

Globus Medical, Inc. is a leading medical device company specializing in innovative healthcare solutions for individuals with musculoskeletal disorders worldwide. Focused on advancing patient care, the company develops and markets a diverse range of spine products tailored to treat conditions such as degenerative spine disease, deformities, tumors, and traumatic injuries. These include traditional fusion implants like pedicle screw systems, rod systems, plating systems, intervertebral spacers, and corpectomy devices.

Globus Medical also pioneers motion preservation technologies that offer alternatives to traditional fusion surgeries. These technologies encompass dynamic stabilization systems, total disc replacement devices, and interspinous distraction devices aimed at maintaining spinal motion and function. Furthermore, the company provides interventional pain management solutions designed to address vertebral compression fractures, enhancing patient comfort and mobility.

In addition to its spine-focused portfolio, Globus Medical extends its expertise to orthopedic trauma treatments, offering a comprehensive array of fracture plates, compression screws, intramedullary nails, and external fixation systems. a. The company's commitment to orthopedic excellence further includes hip and knee joint solutions such as modular hip stems, acetabular cups, and knee arthroplasty implants tailored for posterior stabilization and cruciate retention.

Founded in 2003 and headquartered in Audubon, Pennsylvania, Globus Medical continues to expand its impact within the medical device industry. Beyond its product offerings, the company distributes human cell, tissue, and cellular and tissue-based products, reinforcing its dedication to advancing orthobiologics and regenerative medicine. Globus Medical's innovative approach and commitment to patient-centered solutions solidify its position as a trusted leader in musculoskeletal healthcare innovation.

Globus Medical stock FAQ

What is the Globus Medical stock ticker symbol?

Globus Medical, Inc. trades on the NYSE under the ticker symbol GMED.

What sector and industry is Globus Medical in?

Globus Medical, Inc. is classified in the Healthcare sector, Medical Devices industry.

How many employees does Globus Medical have?

Globus Medical, Inc. has about 6,000 full-time employees.

What were Globus Medical's revenue and earnings last fiscal year?

Globus Medical reported revenue of $2.94B and net income of $537.9M in fiscal 2025, with earnings per share of $4.00. Revenue grew 16.7% from the prior year.

Is Globus Medical in the S&P MidCap 400?

Yes. Globus Medical, Inc. (GMED) is a component of the S&P MidCap 400, the benchmark index of U.S. mid-cap stocks.

Is Globus Medical in the Russell 1000?

Yes. Globus Medical, Inc. (GMED) is a component of the Russell 1000, which tracks roughly the 1,000 largest U.S. companies.

When did Globus Medical go public?

Globus Medical stock began trading on August 3, 2012.

S&P MidCap 400 Healthcare stocks

All S&P MidCap 400 →